Table 1.
Clinical characteristics of the study population
| Patient group n=94 | |
|---|---|
| Age, years | 62±8 |
| Gender, n (male %) | 72 (75.8) |
| Hypertension, n (%) | 57 (61.3) |
| Diabetes mellitus, n (%) | 41 (43.6) |
| Current smoking, n (%) | 51 (54.8) |
| Hyperlipidemia, n (%) | 21 (22.3) |
| Previous MI, n (%) | 29 (30.9) |
| Previous CHF, n (%) | 25 (26.6) |
| Chronic renal failure, n (%) | 3 (3.2) |
| Previous stroke, n (%) | 11 (11.8) |
| PAD, n (%) | 4 (4.3) |
| COPD, n (%) | 21 (22.3) |
| Carotid artery disease, n (%) | 12 (12.8) |
| Stable angina pectoris, n (%) | 55 (59.1) |
| Non-STE-ACS, n (%) | 38 (40.9) |
| Post-op MI, n (%) | 54 (58.7) |
| Post-op AF, n (%) | 31 (33.3) |
| AF duration (h) | 9 (72–1) |
| Three or more stenotic vessels, n (%) | 48 (51.6) |
ACEIs - angiotensin converting enzyme inhibitors; AF - atrial fibrillation; CHF - congestive heart fail-ure; COPD - chronic obstructive pulmonary disease; h - hour; MI - myocardial infarction; Non-STE ACS - non-ST-elevation acute coronary syndrome; PAD - peripheral artery disease; Post-op - postoperative